Skip to Main Content

Login to your account

Show
Forgot password?
Don’t have an account?
Create a Free Account

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

Cancel
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
AJOG Home
Close
  • Home
  • Articles & Issues
    • Back
    • Articles Online First
    • Current Issue
    • List of Issues
    • Supplements
  • Collections
    • Back
    • AJOG Citation Classics
    • AJOG Eponyms
    • Coronavirus Guidance
    • COVID-19 Vaccines and Pregnancy
    • Editors' Choice
    • Focus on Intrauterine Devices
    • Giants in Obstetrics and Gynecology
    • MOC Part II
    • Preeclampsia
    • Press Releases
    • Reports of Major Impact
    • SMFM Supplements
  • For Authors
    • Back
    • About Open Access 
    • Information for Authors
    • Permission to Reuse Published Material
    • Researcher Academy 
    • Submit Your Manuscript 
  • Journal Info
    • Back
    • About Open Access 
    • About the Journal
    • Activate Online Access
    • Advisory Board
    • Affiliated Societies and Meeting Papers
    • Career Opportunities 
    • Contact Information
    • Editors and Editorial Board
    • In Our Third Century
    • Information for Advertisers 
    • Inappropriate Acts 
    • New Content Alerts
    • Pricing
  • Subscribe
  • SMFM Documents
    • Back
    • SMFM Documents by Year
    • SMFM Documents by Subject
  • Society Info
    • Back
    • Affiliates and Papers
    • SMFM Supplements
  • Multimedia
    • Back
    • AGOS Talks
    • Surgeon's Corner
Advanced SearchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
x

Filter:

Filters Applied

  • Reports of Major Impact
  • Research ArticleRemove Research Article filter
Clear all

Publication Date

  • Last 5 Years5
Please choose a date range between 2011 and 2020.

Author

  • Conde-Agudelo, Agustin2
  • Newnham, John P2
  • Alamá, Pilar1
  • Alonso, Roberto1
  • Angkachatchai, Vach1
  • Arnheim-Dahlström, Lisen1
  • Arrese, Catherine A1
  • Askie, Lisa1
  • Balbierz, Amy1
  • Bombard, Allan1
  • Borovac-Pinheiro, Anderson1
  • Bourne, Tom1
  • Breathnach, Fionnuala1
  • Burke, Gerald1
  • Burke, Thomas F1
  • Butler, Trent1
  • Cagasan, Lesley1
  • Cantor, Charles R1
  • Cetingoz, Elcin1
  • Chamley, Larry W1
  • Chen, Pai-Lien1
  • Codoñer, Francisco M1
  • Creasy, George W1
  • Czekierdowski, Artur1
  • Daly, Sean1

Journal

  • American Journal of Obstetrics & Gynecology17

Keyword

  • preeclampsia3
  • small for gestational age3
  • intrauterine growth restriction2
  • maternal mortality2
  • acceptability1
  • adherence1
  • adnexa1
  • adverse neonatal outcome1
  • adverse pregnancy outcome1
  • assisted reproductive techniques1
  • bacterial pathogens1
  • Bakri balloon1
  • birth1
  • birthweight1
  • brain sparing1
  • brain-sparing effect1
  • cardiovascular disease1
  • cerebroplacental ratio1
  • cerebrovascular disease1
  • Doppler1
  • International Ovarian Tumor Analysis1
  • LARC1
  • NIPD1
  • Simple Rules1
  • Viagra1

Reports of Major Impact

17 Results
Subscribe to collection
  • Export
    • PDF
    • Citation

Please select at least one article in order to proceed.

Ok
FilterHide Filter
  • Reports of Major Impact

    Safety and efficacy of sildenafil citrate to reduce operative birth for intrapartum fetal compromise at term: a phase 2 randomized controlled trial

    American Journal of Obstetrics & Gynecology
    Vol. 222Issue 5p401–414Published online: January 21, 2020
    • Jessica Turner
    • Liam Dunn
    • William Tarnow-Mordi
    • Christopher Flatley
    • Vicki Flenady
    • Sailesh Kumar
    Cited in Scopus: 15
    Supplemental MaterialSupplemental material
    • Preview Hide Preview
    • Download PDF
    • Export Citation
    • Video
    Sildenafil citrate is a vasodilator used in erectile dysfunction and pulmonary hypertension. We tested whether it reduces emergency operative births for fetal compromise and improves fetal or uteroplacental perfusion in labor in a phase 2 double-blind randomized controlled trial.
    Safety and efficacy of sildenafil citrate to reduce operative birth for intrapartum fetal compromise at term: a phase 2 randomized controlled trial
  • Reports of Major Impact

    Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis

    American Journal of Obstetrics & Gynecology
    Vol. 222Issue 4p293.e1–293.e52Published online: January 6, 2020
    • Sebastian Suarez
    • Agustin Conde-Agudelo
    • Anderson Borovac-Pinheiro
    • Daniela Suarez-Rebling
    • Melody Eckardt
    • Gerhard Theron
    • and others
    Cited in Scopus: 39
    Online ExtraSupplemental materialCross Reference
    • Preview Hide Preview
    • Download PDF
    • Export Citation
    • Video
    To assess the efficacy, effectiveness, and safety of uterine balloon tamponade for treating postpartum hemorrhage.
    Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis
  • Reports of Major Impact

    Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data

    American Journal of Obstetrics & Gynecology
    Vol. 218Issue 2p161–180Published online: November 16, 2017
    • Roberto Romero
    • Agustin Conde-Agudelo
    • Eduardo Da Fonseca
    • John M. O’Brien
    • Elcin Cetingoz
    • George W. Creasy
    • and others
    Cited in Scopus: 209
    Supplemental materialCross Reference
    • Preview Hide Preview
    • Download PDF
    • Export Citation
    • Video
    The efficacy of vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix has been questioned after publication of the OPPTIMUM study.
    Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data
  • Reports of Major Impact

    Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis

    American Journal of Obstetrics & Gynecology
    Vol. 218Issue 1p1–18Published online: October 30, 2017
    • Michael Fogarty
    • David A. Osborn
    • Lisa Askie
    • Anna Lene Seidler
    • Kylie Hunter
    • Kei Lui
    • and others
    Cited in Scopus: 251
    Supplemental MaterialSupplemental material
    • Preview Hide Preview
    • Download PDF
    • Export Citation
      The effects of delayed cord clamping of the umbilical cord in preterm infants are unclear.
      Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis
    • Reports of Major Impact

      Short-term costs of preeclampsia to the United States health care system

      American Journal of Obstetrics & Gynecology
      Vol. 217Issue 3p237–248.e16Published online: July 11, 2017
      • Warren Stevens
      • Tiffany Shih
      • Devin Incerti
      • Thanh G.N. Ton
      • Henry C. Lee
      • Desi Peneva
      • and others
      Cited in Scopus: 127
      Online ExtraCross ReferenceSupplemental Material
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Preeclampsia is a leading cause of maternal morbidity and mortality and adverse neonatal outcomes. Little is known about the extent of the health and cost burden of preeclampsia in the United States.
        Short-term costs of preeclampsia to the United States health care system
      • Reports of Major Impact

        A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women

        American Journal of Obstetrics & Gynecology
        Vol. 216Issue 4p340–351Published online: February 1, 2017
        • Chen Wang
        • Yumei Wei
        • Xiaoming Zhang
        • Yue Zhang
        • Qianqian Xu
        • Yiying Sun
        • and others
        Cited in Scopus: 163
        Cross Reference
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Obesity and being overweight are becoming epidemic, and indeed, the proportion of such women of reproductive age has increased in recent times. Being overweight or obese prior to pregnancy is a risk factor for gestational diabetes mellitus, and increases the risk of adverse pregnancy outcome for both mothers and their offspring. Furthermore, the combination of gestational diabetes mellitus with obesity/overweight status may increase the risk of adverse pregnancy outcome attributable to either factor alone.
          A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women
        • Original Research Obstetrics

          Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial

          American Journal of Obstetrics & Gynecology
          Vol. 216Issue 3p296.e1–296.e14Published online: January 29, 2017
          • Katie M. Groom
          • Lesley M. McCowan
          • Laura K. Mackay
          • Arier C. Lee
          • Joanne M. Said
          • Stefan C. Kane
          • and others
          Cited in Scopus: 46
          Online ExtraEditor's ChoiceFast Track Articles
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            Preeclampsia and small-for-gestational-age pregnancy are major causes of maternal and perinatal morbidity and mortality. Women with a previous pregnancy affected by these conditions are at an increased risk of recurrence in a future pregnancy. Past trials evaluating the effect of low-molecular-weight heparin for the prevention of recurrence of preeclampsia and small-for-gestational-age pregnancy have shown conflicting results with high levels of heterogeneity displayed when trials were compared.
            Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial
          • Reports of Major Impact
            Open Access

            Reducing preterm birth by a statewide multifaceted program: an implementation study

            American Journal of Obstetrics & Gynecology
            Vol. 216Issue 5p434–442Published online: November 24, 2016
            • John P. Newnham
            • Scott W. White
            • Suzanne Meharry
            • Han-Shin Lee
            • Michelle K. Pedretti
            • Catherine A. Arrese
            • and others
            Cited in Scopus: 54
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              A comprehensive preterm birth prevention program was introduced in the state of Western Australia encompassing new clinical guidelines, an outreach program for health care practitioners, a public health program for women and their families based on print and social media, and a new clinic at the state’s sole tertiary level perinatal center for referral of those pregnant women at highest risk. The initiative had the single aim of safely lowering the rate of preterm birth.
              Reducing preterm birth by a statewide multifaceted program: an implementation study
            • Original Research Obstetrics

              Evaluation of normalization of cerebro-placental ratio as a potential predictor for adverse outcome in SGA fetuses

              American Journal of Obstetrics & Gynecology
              Vol. 216Issue 3p285.e1–285.e6Published online: November 10, 2016
              • Cathy Monteith
              • Karen Flood
              • Sieglinde Mullers
              • Julia Unterscheider
              • Fionnuala Breathnach
              • Sean Daly
              • and others
              Cited in Scopus: 14
              Online ExtraEditor's Choice
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                Intrauterine growth restriction accounts for a significant proportion of perinatal morbidity and mortality currently encountered in obstetric practice. The primary goal of antenatal care is the early recognition of such conditions to allow treatment and optimization of both maternal and fetal outcomes. Management of pregnancies complicated by intrauterine growth restriction remains one of the greatest challenges in obstetrics. Frequently, however, clinical evidence of underlying uteroplacental dysfunction may only emerge at a late stage in the disease process.
                Evaluation of normalization of cerebro-placental ratio as a potential predictor for adverse outcome in SGA fetuses
              • Original Research Gynecology

                Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial

                American Journal of Obstetrics & Gynecology
                Vol. 216Issue 3p264.e1–264.e7Published online: November 5, 2016
                • Kristina Elfgren
                • K. Miriam Elfström
                • Pontus Naucler
                • Lisen Arnheim-Dahlström
                • Joakim Dillner
                Cited in Scopus: 32
                Online ExtraEditor's ChoiceCross Reference
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  Introduction of human papillomavirus–based screening is ongoing in many countries, given its higher sensitivity and longer-lasting protection compared with cytology-based screening. However, optimal clinical management of human papillomavirus–positive but cytology-negative women is unclear, and additional studies with clinical follow-up are warranted.
                  Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial
                • Original Research Obstetrics

                  Gestational hypertension is associated with increased risk of type 2 diabetes in adult offspring: the Helsinki Birth Cohort Study

                  American Journal of Obstetrics & Gynecology
                  Vol. 216Issue 3p281.e1–281.e7Published online: November 4, 2016
                  • Eero Kajantie
                  • Clive Osmond
                  • Johan G. Eriksson
                  Cited in Scopus: 33
                  Online ExtraEditor's Choice
                  • Preview Hide Preview
                  • Download PDF
                  • Export Citation
                    Women with hypertensive disorders in pregnancy are at an increased risk of cardiovascular disease and type 2 diabetes later in life. Offspring born from these hypertensive pregnancies have increased levels of cardiovascular risk factors; whether they are at an increased risk of type 2 diabetes is not known.
                    Gestational hypertension is associated with increased risk of type 2 diabetes in adult offspring: the Helsinki Birth Cohort Study
                  • Report of Major Impact

                    Evidence that the endometrial microbiota has an effect on implantation success or failure

                    American Journal of Obstetrics & Gynecology
                    Vol. 215Issue 6p684–703Published online: October 5, 2016
                    • Inmaculada Moreno
                    • Francisco M. Codoñer
                    • Felipe Vilella
                    • Diana Valbuena
                    • Juan F. Martinez-Blanch
                    • Jorge Jimenez-Almazán
                    • and others
                    Cited in Scopus: 307
                    Supplemental MaterialCross Reference
                    • Preview Hide Preview
                    • Download PDF
                    • Export Citation
                      Bacterial cells in the human body account for 1–3% of total body weight and are at least equal in number to human cells. Recent research has focused on understanding how the different bacterial communities in the body (eg, gut, respiratory, skin, and vaginal microbiomes) predispose to health and disease. The microbiota of the reproductive tract has been inferred from the vaginal bacterial communities, and the uterus has been classically considered a sterile cavity. However, while the vaginal microbiota has been investigated in depth, there is a paucity of consistent data regarding the existence of an endometrial microbiota and its possible impact in reproductive function.
                      Evidence that the endometrial microbiota has an effect on implantation success or failure
                    • Reports of Major Impact

                      Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial

                      American Journal of Obstetrics & Gynecology
                      Vol. 216Issue 2p101–109Published online: September 19, 2016
                      • David Hubacher
                      • Hannah Spector
                      • Charles Monteith
                      • Pai-Lien Chen
                      • Catherine Hart
                      Cited in Scopus: 46
                      Cross Reference
                      • Preview Hide Preview
                      • Download PDF
                      • Export Citation
                        Measures of contraceptive effectiveness combine technology and user-related factors. Observational studies show higher effectiveness of long-acting reversible contraception compared with short-acting reversible contraception. Women who choose long-acting reversible contraception may differ in key ways from women who choose short-acting reversible contraception, and it may be these differences that are responsible for the high effectiveness of long-acting reversible contraception. Wider use of long-acting reversible contraception is recommended, but scientific evidence of acceptability and successful use is lacking in a population that typically opts for short-acting methods.
                        Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial
                      • Original Research Obstetrics

                        Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor

                        American Journal of Obstetrics & Gynecology
                        Vol. 216Issue 3p283.e1–283.e14Published online: August 24, 2016
                        • Jonathan W. Paul
                        • Susan Hua
                        • Marina Ilicic
                        • Jorge M. Tolosa
                        • Trent Butler
                        • Sarah Robertson
                        • and others
                        Cited in Scopus: 42
                        Online ExtraEditor's ChoiceSupplemental MaterialCross Reference
                        • Preview Hide Preview
                        • Download PDF
                        • Export Citation
                          The ability to provide safe and effective pharmacotherapy during obstetric complications, such as preterm labor or postpartum hemorrhage, is hampered by the systemic toxicity of therapeutic agents leading to adverse side effects in the mother and fetus. Development of novel strategies to target tocolytic and uterotonic agents specifically to uterine myocytes would improve therapeutic efficacy while minimizing the risk of side effects. Ligand-targeted liposomes have emerged as a reliable and versatile platform for targeted drug delivery to specific cell types, tissues or organs.
                          Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor
                        • Reports of Major Impact

                          Site of delivery contribution to black-white severe maternal morbidity disparity

                          American Journal of Obstetrics & Gynecology
                          Vol. 215Issue 2p143–152Published online: May 12, 2016
                          • Elizabeth A. Howell
                          • Natalia N. Egorova
                          • Amy Balbierz
                          • Jennifer Zeitlin
                          • Paul L. Hebert
                          Cited in Scopus: 113
                          Cross Reference
                          • Preview Hide Preview
                          • Download PDF
                          • Export Citation
                            The black-white maternal mortality disparity is the largest disparity among all conventional population perinatal health measures, and the mortality gap between black and white women in New York City has nearly doubled in recent years. For every maternal death, 100 women experience severe maternal morbidity, a life-threatening diagnosis, or undergo a life-saving procedure during their delivery hospitalization. Like maternal mortality, severe maternal morbidity is more common among black than white women.
                            Site of delivery contribution to black-white severe maternal morbidity disparity
                          • Reports of Major Impact Gynecology

                            Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group

                            American Journal of Obstetrics & Gynecology
                            Vol. 214Issue 4p424–437Published online: January 18, 2016
                            • Dirk Timmerman
                            • Ben Van Calster
                            • Antonia Testa
                            • Luca Savelli
                            • Daniela Fischerova
                            • Wouter Froyman
                            • and others
                            Cited in Scopus: 137
                            Supplemental materialCross Reference
                            • Preview Hide Preview
                            • Download PDF
                            • Export Citation
                            • Video
                            Accurate methods to preoperatively characterize adnexal tumors are pivotal for optimal patient management. A recent metaanalysis concluded that the International Ovarian Tumor Analysis algorithms such as the Simple Rules are the best approaches to preoperatively classify adnexal masses as benign or malignant.
                            Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
                          • Reports of major impact

                            Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting

                            American Journal of Obstetrics & Gynecology
                            Vol. 204Issue 3p205.e1–205.e11Published online: February 11, 2011
                            • Mathias Ehrich
                            • Cosmin Deciu
                            • Tricia Zwiefelhofer
                            • John A. Tynan
                            • Lesley Cagasan
                            • Roger Tim
                            • and others
                            Cited in Scopus: 378
                            Online ExtraEditor's ChoiceEditor's CommentaryCross-referenceArticles in full
                            • Preview Hide Preview
                            • Download PDF
                            • Export Citation
                              We sought to evaluate a multiplexed massively parallel shotgun sequencing assay for noninvasive trisomy 21 detection using circulating cell-free fetal DNA.
                              Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting
                            Page 1 of 1
                            • Home
                            • Articles & Issues
                            • Articles Online First
                            • Current Issue
                            • List of Issues
                            • Supplements
                            • Collections
                            • AJOG Citation Classics
                            • Coronavirus Guidance
                            • COVID-19 Vaccines and Pregnancy
                            • AJOG Eponyms
                            • Editors' Choice
                            • Focus on Intrauterine Devices
                            • Giants in Obstetrics and Gynecology
                            • MOC Part II
                            • Preeclampsia
                            • Press Releases
                            • Reports of Major Impact
                            • SMFM Supplements
                            • For Authors
                            • About Open Access
                            • Information for Authors
                            • Permission to Reuse Published Material
                            • Researcher Academy
                            • Submit Your Manuscript
                            • Journal Info
                            • About Open Access
                            • About the Journal
                            • Activate Online Access
                            • Advisory Board
                            • Affiliated Societies and Meeting Papers
                            • Career Opportunities
                            • Contact Information
                            • Editors and Editorial Board
                            • In Our Third Century
                            • Information for Advertisers
                            • Inappropriate Acts
                            • New Content Alerts
                            • Pricing
                            • Subscribe
                            • SMFM Documents
                            • SMFM Documents by Year
                            • SMFM Documents by Subject
                            • Society Info
                            • Affiliates and Papers
                            • SMFM Supplements
                            • Multimedia
                            • AGOS Talks
                            • Surgeon's Corner
                            • Follow Us
                            • Facebook
                            • Twitter
                            • Instagram
                            We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
                            Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.

                            • Privacy Policy  
                            • Terms and Conditions  
                            • Accessibility  
                            • Help & Contact

                            RELX